• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Alignment Healthcare Inc.

    2/14/24 10:04:40 AM ET
    $ALHC
    Medical Specialities
    Health Care
    Get the next $ALHC alert in real time by email
    SC 13G 1 alhc13gdec23.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. ) ALIGNMENT HEALTHCARE INC (Name of Issuer) COMMON STOCK (Title of Class of Securities) 01625V104 (CUSIP NUMBER) December 31, 2023 (Date of Event which Requires Filing of Statement) Check the appropriate box to designate the Rule pursuant to which this Schedule is filed: [x] Rule 13d - 1(b) Rule 13d - 1(c) Rule 13d - 1(d) 1. Name of Reporting Person T. Rowe Price Investment Management, Inc. 85-4328500 2. Check the Appropriate Box if a Member of a Group NOT APPLICABLE 3. SEC Use Only 4. Citizenship or Place of Organization Maryland Number of Shares Beneficially Owned by Each Reporting Person With 5. Sole Voting Power* 4,109,754 6. Shared Voting Power* 0 7. Sole Dispositive Power* 12,075,504 8. Shared Dispositive Power 0 9. Aggregate Amount Beneficially Owned by Each Reporting Person 12,075,504 10. Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares NOT APPLICABLE 11. Percent of Class Represented by Amount in Row 9 6.4% 12. Type of Reporting Person IA *Any shares reported in Items 5 and 6 are also reported in Item 7. Item 1(a) Name of Issuer: ALIGNMENT HEALTHCARE INC Item 1(b) Address of Issuer's Principal Executive Offices: 1100 W. TOWN AND COUNTRY ROAD, SUITE 1600, ORANGE, CALIFORNIA 92868 Item 2(a) Name of Person(s) Filing: (1) T. Rowe Price Investment Management, Inc. (Price Investment Management) Item 2(b) Address of Principal Business Office: 101 E. Pratt Street, Baltimore, MD 21201 Item 2(c) Citizenship or Place of Organization: (1) Maryland Item 2(d) Title of Class of Securities: COMMON STOCK Item 2(e) Cusip Number: 01625V104 Item 3: The person filing this Schedule 13G is an: X Investment Adviser registered under Section 203 of the Investment Advisers Act of 1940 Item 4: Reference is made to Items 5-11 on the preceding pages of this Schedule 13G. Item 5: Ownership of Five Percent or Less of a Class Not Applicable Item 6: Ownership of More than Five Percent on Behalf of Another Person (1) Price Investment Management does not serve as custodian of the assets of any of its clients; accordingly, in each instance only the client or the client's custodian or trustee bank has the right to receive dividends paid with respect to, and proceeds from the sale of, such securities. The ultimate power to direct the receipt of dividends paid with respect to, and the proceeds from the sale of, such securities, is vested in the individual and institutional clients which Price Investment Management serves as investment adviser. Any and all discretionary authority which has been delegated to Price Investment Management may be revoked in whole or in part at any time. Except as may be indicated if this is a joint filing with one of the registered investment companies sponsored by Price Investment Management which it also serves as investment adviser ("T. Rowe Price Funds"), not more than 5% of the class of such securities is owned by any one client subject to the investment advice of Price Investment Management. Item 7: Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. Not Applicable Item 8: Identification and Classification of Members of the Group Not Applicable Item 9: Notice of Dissolution of Group Not Applicable Item 10: Certification By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. T. Rowe Price Investment Management, Inc. hereby declares and affirms that the filing of Schedule 13G shall not be construed as an admission that Price Investment Management is the beneficial owner of the securities referred to, which beneficial ownership is expressly denied. Signature. After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. T. Rowe Price Investment Management, Inc. Date: February 14, 2024 Signature: /s/ Armando Capasso Name & Title: Armando Capasso, Vice President 12/31/2023
    Get the next $ALHC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ALHC

    DatePrice TargetRatingAnalyst
    12/3/2024$13.00 → $17.00Equal-Weight → Overweight
    Stephens
    10/11/2024Sector Weight
    KeyBanc Capital Markets
    5/30/2024$10.00Outperform
    Robert W. Baird
    5/30/2024$7.75 → $11.00Neutral → Buy
    BofA Securities
    5/8/2024$6.00 → $8.00Neutral → Overweight
    Piper Sandler
    3/6/2024$4.50Underweight
    Barclays
    3/6/2024$12.00 → $6.00Overweight → Neutral
    Piper Sandler
    1/24/2024$11.00Buy
    Stifel
    More analyst ratings

    $ALHC
    Leadership Updates

    Live Leadership Updates

    See more
    • Alignment Healthcare Appoints Sebastian Burzacchi to New Role of Chief Operating Officer of Management Services Organization and Andreas Wagner to Chief People Officer

      ORANGE, Calif., Jan. 09, 2024 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC) today announced that Sebastian Burzacchi will join as the new chief operating officer of its management services organization (MSO), and Andreas Wagner will serve as chief people officer, effective immediately. Sebastian Burzacchi, Chief Operating Officer of MSOReporting to Alignment founder and CEO John Kao, Sebastian Burzacchi will direct initiatives that strengthen a core value of the company – supporting doctors. This includes a focus on enhancing provider partnerships and ensuring a seamless experience for doctors with Alignment. "We are thrilled to welcome Sebastian to our leadership team, br

      1/9/24 8:00:00 AM ET
      $ALHC
      Medical Specialities
      Health Care
    • Alignment Health Welcomes New Chief People Officer as It Scales to Serve More Seniors Nationwide

      ORANGE, Calif., July 06, 2023 (GLOBE NEWSWIRE) -- Alignment Health — a consumer brand name of Alignment Healthcare, Inc. (NASDAQ:ALHC), a tech-enabled Medicare Advantage company — today announced the appointment of Melinda Kimbro as its new chief people officer. Kimbro joined on June 30 to lead the company's human resources (HR) function and will oversee all aspects of the Alignment employee experience, including talent acquisition, culture, diversity, equity and inclusion, total rewards, and facilities. She will also spearhead the strategic development of internal talent to help further drive innovation and provide rich, ongoing career growth opportunities for employees. "Championing ou

      7/6/23 8:00:00 AM ET
      $ALHC
      $VSAT
      Medical Specialities
      Health Care
      Radio And Television Broadcasting And Communications Equipment
      Technology
    • Alignment Health Appoints 3 New Executives to Further Drive Strategic Growth Nationally

      ORANGE, Calif., June 06, 2023 (GLOBE NEWSWIRE) -- Alignment Health, a consumer brand name of Alignment Healthcare, Inc. (NASDAQ:ALHC), a tech-enabled Medicare Advantage (MA) company, is strengthening its sales team with the addition of three executives who will help propel the company's nationwide growth as it champions a new path in senior care. Appointed as Health Plan Chief Growth Officer, Todd Macaluso will lead the company's health plan growth by increasing net membership and improving the overall experience, execution, research and development efforts. David Milligan and Joe Kanatzar will serve as senior vice presidents of sales for California and all states outside California, resp

      6/6/23 8:00:00 AM ET
      $ALHC
      Medical Specialities
      Health Care

    $ALHC
    SEC Filings

    See more
    • SEC Form 144 filed by Alignment Healthcare Inc.

      144 - Alignment Healthcare, Inc. (0001832466) (Subject)

      5/1/25 4:50:50 PM ET
      $ALHC
      Medical Specialities
      Health Care
    • SEC Form 10-Q filed by Alignment Healthcare Inc.

      10-Q - Alignment Healthcare, Inc. (0001832466) (Filer)

      5/1/25 4:30:48 PM ET
      $ALHC
      Medical Specialities
      Health Care
    • Alignment Healthcare Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Alignment Healthcare, Inc. (0001832466) (Filer)

      5/1/25 4:01:09 PM ET
      $ALHC
      Medical Specialities
      Health Care

    $ALHC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Alignment Healthcare Reports Strong First Quarter 2025 Results; Exceeds High-End of Expectations On 4 Critical KPIs; Raises Midpoint of 2025 Guidance; Announces CFO Transition

      Delivers Q1 revenue of $926.9 million, up 47.5% year over year, and grows Medicare Advantage (MA) membership by 31.7% to approximately 217,500 membersExceeds high-end of Q1 guidance on membership, revenue, adjusted gross profit and adjusted EBITDARaises midpoint of outlook ranges for 2025 year-end membership, revenue, adjusted gross profit and adjusted EBITDA, supported by strong first-quarter clinical performance and enrollment growth momentumAnnounces transition of Thomas Freeman from Chief Financial Officer (CFO) to Strategic Advisor to the CEO; names finance veteran Jim Head as CFO ORANGE, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC), today reporte

      5/1/25 4:01:00 PM ET
      $ALHC
      Medical Specialities
      Health Care
    • Alignment Healthcare to Present at the BofA Securities Healthcare Conference

      ORANGE, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC), today announced that it will present at the BofA Securities Healthcare Conference on Wednesday, May 14, at 2:20 p.m. PDT. A webcast and replay of the presentations will be available on Alignment's investor relations website at https://ir.alignmenthealth.com/. About Alignment HealthcareAlignment Health is championing a new path in senior care that empowers members to age well and live their most vibrant lives. A consumer brand name of Alignment Healthcare (NASDAQ:ALHC), Alignment Health's mission-focused team makes high-quality, low-cost care a reality for its Medicare Advantage members every day.

      4/28/25 8:00:00 AM ET
      $ALHC
      Medical Specialities
      Health Care
    • Alignment Healthcare Strengthens Leadership to Scale its AI-Enabled Medicare Advantage Platform with Two Key Appointments

      ORANGE, Calif., April 15, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC) today announced pivotal leadership appointments that underscore its dedication to transforming senior health care through technology and exceptional member care. Dr. Arta Bakshandeh has been named President of AVA®, and Aly Duzich has been promoted to Chief Experience Officer. Driving Next-Generation InnovationFor more than 10 years, Alignment has harnessed trusted artificial intelligence (AI) through AVA – the company's proprietary Medicare Advantage platform – to drive actionable clinical insights that improve senior health outcomes and quality of care. Dr. Bakshandeh's appointment reinforces Ali

      4/15/25 8:00:00 AM ET
      $ALHC
      Medical Specialities
      Health Care

    $ALHC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Mccarthy Margaret M was granted 1,290 shares, increasing direct ownership by 1% to 130,168 units (SEC Form 4)

      4 - Alignment Healthcare, Inc. (0001832466) (Issuer)

      5/9/25 5:11:46 PM ET
      $ALHC
      Medical Specialities
      Health Care
    • Director Konowiecki Joseph S was granted 12,903 shares, increasing direct ownership by 1% to 1,177,049 units (SEC Form 4)

      4 - Alignment Healthcare, Inc. (0001832466) (Issuer)

      5/9/25 5:07:27 PM ET
      $ALHC
      Medical Specialities
      Health Care
    • Amendment: Director Konowiecki Joseph S was granted 17,000 shares, increasing direct ownership by 1% to 1,275,221 units (SEC Form 4)

      4/A - Alignment Healthcare, Inc. (0001832466) (Issuer)

      5/9/25 5:01:15 PM ET
      $ALHC
      Medical Specialities
      Health Care

    $ALHC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Alignment Healthcare upgraded by Stephens with a new price target

      Stephens upgraded Alignment Healthcare from Equal-Weight to Overweight and set a new price target of $17.00 from $13.00 previously

      12/3/24 7:13:50 AM ET
      $ALHC
      Medical Specialities
      Health Care
    • KeyBanc Capital Markets initiated coverage on Alignment Healthcare

      KeyBanc Capital Markets initiated coverage of Alignment Healthcare with a rating of Sector Weight

      10/11/24 7:29:52 AM ET
      $ALHC
      Medical Specialities
      Health Care
    • Robert W. Baird initiated coverage on Alignment Healthcare with a new price target

      Robert W. Baird initiated coverage of Alignment Healthcare with a rating of Outperform and set a new price target of $10.00

      5/30/24 7:29:29 AM ET
      $ALHC
      Medical Specialities
      Health Care

    $ALHC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Alignment Healthcare Inc.

      SC 13G/A - Alignment Healthcare, Inc. (0001832466) (Subject)

      11/14/24 5:57:27 PM ET
      $ALHC
      Medical Specialities
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Alignment Healthcare Inc.

      SC 13G/A - Alignment Healthcare, Inc. (0001832466) (Subject)

      11/14/24 1:28:35 PM ET
      $ALHC
      Medical Specialities
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Alignment Healthcare Inc.

      SC 13G/A - Alignment Healthcare, Inc. (0001832466) (Subject)

      11/12/24 1:26:14 PM ET
      $ALHC
      Medical Specialities
      Health Care

    $ALHC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Kao John E bought $496,779 worth of shares (103,000 units at $4.82), increasing direct ownership by 4% to 2,745,253 units (SEC Form 4)

      4 - Alignment Healthcare, Inc. (0001832466) (Issuer)

      3/18/24 5:27:36 PM ET
      $ALHC
      Medical Specialities
      Health Care

    $ALHC
    Financials

    Live finance-specific insights

    See more
    • Alignment Healthcare Reports Strong First Quarter 2025 Results; Exceeds High-End of Expectations On 4 Critical KPIs; Raises Midpoint of 2025 Guidance; Announces CFO Transition

      Delivers Q1 revenue of $926.9 million, up 47.5% year over year, and grows Medicare Advantage (MA) membership by 31.7% to approximately 217,500 membersExceeds high-end of Q1 guidance on membership, revenue, adjusted gross profit and adjusted EBITDARaises midpoint of outlook ranges for 2025 year-end membership, revenue, adjusted gross profit and adjusted EBITDA, supported by strong first-quarter clinical performance and enrollment growth momentumAnnounces transition of Thomas Freeman from Chief Financial Officer (CFO) to Strategic Advisor to the CEO; names finance veteran Jim Head as CFO ORANGE, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC), today reporte

      5/1/25 4:01:00 PM ET
      $ALHC
      Medical Specialities
      Health Care
    • Alignment Healthcare to Announce First Quarter 2025 Financial Results and Host Conference Call Thursday, May 1, 2025

      ORANGE, Calif., April 11, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC), will release its first quarter 2025 financial results on Thursday, May 1, 2025, after market close. Following the release, the company will host a conference call to review its financial results at 5 p.m. EDT. Conference Call DetailsA live audio webcast will be available online at https://ir.alignmenthealth.com/. At the start of the conference call, participants may access the webcast at the following link: https://edge.media-server.com/mmc/p/frtkwokr A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call at the same web links and will

      4/11/25 8:00:00 AM ET
      $ALHC
      Medical Specialities
      Health Care
    • Alignment Healthcare Reports Fourth Quarter and Full-Year 2024 Results; Provides Full-Year 2025 Financial Guidance

      Reports 189,100 health plan members as of Dec. 31, 2024, up 58.6% year-over-year, beating year-end expectationsAchieves first full year of positive adjusted EBITDA as a public company, driven by operating leverage and strong medical benefits ratio performanceRaises midpoint of 2025 health plan membership guidance by 2,000 to reflect strong open enrollment period momentumIntroduces 2025 revenue guidance of $3.72 billion to $3.78 billion, representing 37.6%-39.6% growth year-over-year, and adjusted EBITDA of $35 million to $60 million ORANGE, Calif., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC), today reported financial results for its fourth quarter and full y

      2/27/25 4:01:00 PM ET
      $ALHC
      Medical Specialities
      Health Care